Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MS › Southaven › NPI 1912982521
Lab

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings was paid $58K by Medicaid between Jan 2018 and Feb 2022, across 10 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 71% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA HOLDINGS
SOUTHAVEN, MS 38671
33aNPI1912982521assigned 12/07/2005
28Total paid$58K
24GClaims1,895
24DCodes billed10
24AFirst – last monthJan 2018 – Feb 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in Mississippi

Rank by total paid#22 of 35
Median peer was paid$136K
This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$2.5K$5.0K$7.5K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018889$30K
2019658$26K
202046$1K
2021284$927.62
202218$89.56
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 71% 1,151 920 $41K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 26% 264 179 $15K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.0% 196 154 $1K
83615 <1% 40 28 $143.23
82565 <1% 40 28 $126.04
84450 <1% 40 28 $122.71
82570 <1% 39 27 $118.05
84550 <1% 40 28 $107.19
85652 <1% 46 45 $91.24
84156 <1% 39 27 $86.85

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VP)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.